Letter to the Editor: comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis

J Comp Eff Res. 2021 Dec;10(17):1265-1266. doi: 10.2217/cer-2021-0123. Epub 2021 Oct 5.
No abstract available

Keywords: disease-modifying therapies; multiple sclerosis; network meta-analysis; relapsing multiple sclerosis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Multiple Sclerosis*
  • Multiple Sclerosis, Relapsing-Remitting* / drug therapy
  • Network Meta-Analysis

Substances

  • Antibodies, Monoclonal, Humanized
  • ofatumumab